Plaque Psoriasis. Psoriasis vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with the age between 18 to 50 years old; diagnosis of mild to moderate plaque type psoriasis on both sides of the body; not being under medical treatment for the past two months. Exclusion criteria: pregnancy; lactation; suffering from a major illness (such as cardiovascular disease, acute renal or liver disease, cancer or active malignancy); not having plaque psoriasis on both sides of the body.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema, Thickness, Scaling. Timepoint: At the end of week 4. Method of measurement: Modified psoriasis area severity index (PASI) scores.;Tissue TNFa Level. Timepoint: At the end of Week 4. Method of measurement: Mouse anti-human TNFa (28401.111) monoclonal antibody. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: At the end of week 4. Method of measurement: Questionnaire, Photography, Scoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University, Pharmaceutical Sciences Branch, Faculty of Pharmacy